EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Regulated vascular smooth muscle cell death in vascular diseases

Zheng Yin, Jishou Zhang, Zican Shen, Juan-Juan Qin, Jun Wan iD, Menglong Wang

Cell Proliferation · 2024-11 · 57 (11)

DOI: 10.1111/cpr.13688 ↗

At a glance

Übersichtsarbeit in Cell Proliferation, published online on 2024-06-14. Written by Zheng Yin and 5 co-authors. Institution: Department of Cardiology, Renmin Hospital of Wuhan University, Department of Geriatrics, Zhongnan Hospital of Wuhan University, Wuhan University, Wuh…. Major MEDLINE topics: Muscle, Smooth, Vascular, Vascular Diseases, Myocytes, Smooth Muscle. Cited 47 times so far (Crossref); 165 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, Youth Interdisciplinary Special Fund of Zhongnan Hospital of Wuhan University, Excellent Doctoral Program of Zhongnan Hospital of Wuhan University.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Regulated cell death (RCD) is a complex process that involves several cell types and plays a crucial role in vascular diseases. Vascular smooth muscle cells (VSMCs) are the predominant elements of the medial layer of blood vessels, and their regulated death contributes to the pathogenesis of vascular diseases. The types of regulated VSMC death include apoptosis, necroptosis, pyroptosis, ferroptosis, parthanatos, and autophagy‐dependent cell death (ADCD). In this review, we summarize the current evidence of regulated VSMC death pathways in major vascular diseases, such as atherosclerosis, vascular calcification, aortic aneurysm and dissection, hypertension, pulmonary arterial hypertension, neointimal hyperplasia, and inherited vascular diseases. All forms of RCD constitute a single, coordinated cell death system in which one pathway can compensate for another during disease progression. Pharmacologically targeting RCD pathways has potential for slowing and reversing disease progression, but challenges remain. A better understanding of the role of regulated VSMC death in vascular diseases and the underlying mechanisms may lead to novel pharmacological developments and help clinicians address the residual cardiovascular risk in patients with cardiovascular diseases.

Subjects

MeSH terms (MEDLINE)

Muscle, Smooth, VascularVascular DiseasesMyocytes, Smooth MuscleHumansAnimalsRegulated Cell DeathApoptosisCell Death

Authors and institutions

  • Department of Cardiology, Renmin Hospital of Wuhan University, Department of Geriatrics, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China.
  • Cardiovascular Research Institute, Wuhan University, Wuhan, China.
  • Hubei Key Laboratory of Cardiology, Wuhan, China.
  • Center for Healthy Aging, Wuhan University School of Nursing, Wuhan, China.

ORCID profiles: Jun Wan

Funding

  • National Natural Science Foundation of China
  • Youth Interdisciplinary Special Fund of Zhongnan Hospital of Wuhan University
  • Excellent Doctoral Program of Zhongnan Hospital of Wuhan University

Cite

APA

Yin, Z., Zhang, J., Shen, Z., Qin, J. J., Wan, J., & Wang, M. (2024). Regulated vascular smooth muscle cell death in vascular diseases. Cell Proliferation, 57(11). https://doi.org/10.1111/cpr.13688

Vancouver

Yin Z, Zhang J, Shen Z, Qin JJ, Wan J, Wang M. Regulated vascular smooth muscle cell death in vascular diseases. Cell Proliferation. 2024;57(11). doi:10.1111/cpr.13688

BibTeX
@article{Yin2024,
  author = {Yin, Zheng and Zhang, Jishou and Shen, Zican and Qin, Juan-Juan and Wan, Jun and Wang, Menglong},
  title = {Regulated vascular smooth muscle cell death in vascular diseases},
  journal = {Cell Proliferation},
  year = {2024},
  volume = {57},
  number = {11},
  doi = {10.1111/cpr.13688}
}
Start for free →